Market Exclusive

Amgen Inc. (NASDAQ:AMGN) reported earnings of $3.27 per share beating Walls Streets expectations.

Amgen Inc. (NASDAQ:AMGN) reported Q2 2017 earnings this Afternoon, coming in at $3.27 per share, beating Wall Street’s estimates of $3.11 per Share. Revenue for the quarter came in at $5.81 billion beating analyst estimates of $5.67 billion

Analyst Coverage For Amgen Inc. (NASDAQ:AMGN)
These are 11 Hold Ratings, 11 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Amgen Inc. (NASDAQ:AMGN) is Buy (Score: 2.57) with a consensus target price of $185.68 , a potential (2.65% upside)Recent Insider Trading for Amgen Inc. (NASDAQ:AMGN)

Dividend History for Amgen Inc. (NASDAQ:AMGN)

Recent Trading for Amgen Inc. (NASDAQ:AMGN) Shares of Amgen Inc. closed the previous trading session at 180.89 down -0.17 -0.09% with 3,343,223 shares trading hands.

Exit mobile version